Stents, Drug Eluting

Cath Lab

Stents, Drug Eluting

Zilver PTX Drug Eluting Stent Recalled Due to Catheter Separation Issue

Cook Medical has initiated a global voluntary recall of its Zilver PTX Drug Eluting Peripheral Stent based on its investigation into a small number of complaints that the delivery system of the device had separated at the tip of the inner catheter...

Promus Premier DES Receives European Approval

Boston Scientific received CE mark approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation durable polymer drug-eluting stent (DES) technology. The Promus Premier is designed to imp...

Biosensors Receives CE Mark Approval for BioFreedom

Biosensors International has announced CE mark approval for its polymer-free drug-coated stent (DCS), BioFreedom.

Abbott Absorb bioresorbable stent
Abbott Initiates U.S. Trial for Fully Bioresorbable Stent

Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The randomized controlled trial will enroll about 2,250 patients and compare the performance of Abbott's drug-eluting Absorb boresorbable vascular s...

Zilver PTX Drug Eluting Stent Recalled Due to Catheter...
Cook Medical has initiated a global voluntary recall of its Zilver PTX Drug Eluting Peripheral Stent based on its investigation into a small number of...
Medtronic Resolute Drug Eluting Stent Dual Antiplatelet Therapy Clinical
With Resolute Stent, Interrupting DAPT After One Month...
Cardiologists at ACC.13 learned that patients with coronary artery disease who received a Resolute drug-eluting stent from Medtronic Inc. as participants in...
First Patient Treated in DIRECT II Study of Svelte DES With...
Svelte Medical Systems announced treatment of the first patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug...
OrbusNeich Files Patent Infringement Actions Against Boston...
OrbusNeich announced that OrbusNeich Medical GmbH has commenced patent infringement actions in Germany and The Netherlands against Boston Scientific Corp. and...
Medtronic Resolute Integrity Stent FDA Approval 34, 38 mm
New Sizes of Medtronic Resolute Integrity Target Long Coronary Lesions
The 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for
Zilver PTX is First Drug-Eluting Peripheral Stent
Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review...
FDA Clears 32, 38 MM Lengths for Promus Element Plus Stent
The 32 and 38 mm lengths of Boston Scientific's Promus Element Plus everolimus-eluting platinum chromium (PtCr) coronary stent system, the...
Medtronic Offers Resolute Integrity Drug-Eluting Stent for Coronary Disease
U.S. Food and Drug Administration (FDA) approved Medtronic's Resolute Integrity zotarolimus-eluting stent for the treatment of...
View All »

Articles

Promus Premier DES Receives European Approval
Boston Scientific received CE mark approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation...
First U.S. Patient Treated with Cook Medical’s Zilver PTX...
January 16, 2013 — Just weeks after the Food and Drug Administration (FDA) approved Cook Medical’s Zilver PTX drug-eluting peripheral stent,...
Abbott Absorb bioresorbable stent
Abbott Initiates U.S. Trial for Fully Bioresorbable Stent
Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The randomized controlled trial will enroll about 2,250...
FDA Approves Abbott’s Next-Generation Xience Xpedition Drug...
Abbott announced that the Xience Xpedition everolimus-eluting coronary stent system received U.S. Food and Drug Administration (FDA) approval and is...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
10 weeks 5 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 16 hours ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
18 weeks 6 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...